Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Nat Med. 2015 Aug;21(8):922-6. doi: 10.1038/nm.3884. Epub 2015 Jul 20.
Nat Med. 2015.
PMID: 26193343
Free PMC article.
Clinical Trial.
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.
Noy A, de Vos S, Thieblemont C, Martin P, Flowers CR, Morschhauser F, Collins GP, Ma S, Coleman M, Peles S, Smith S, Barrientos JC, Smith A, Munneke B, Dimery I, Beaupre DM, Chen R.
Noy A, et al. Among authors: munneke b.
Blood. 2017 Apr 20;129(16):2224-2232. doi: 10.1182/blood-2016-10-747345. Epub 2017 Feb 6.
Blood. 2017.
PMID: 28167659
Free PMC article.
Clinical Trial.
Item in Clipboard
Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.
Furtado M, Wang ML, Munneke B, McGreivy J, Beaupre DM, Rule S.
Furtado M, et al. Among authors: munneke b.
Br J Haematol. 2015 Jul;170(1):131-4. doi: 10.1111/bjh.13275. Epub 2015 Jan 6.
Br J Haematol. 2015.
PMID: 25559624
Free article.
No abstract available.
Item in Clipboard
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.
Jaglowski SM, Jones JA, Nagar V, Flynn JM, Andritsos LA, Maddocks KJ, Woyach JA, Blum KA, Grever MR, Smucker K, Ruppert AS, Heerema NA, Lozanski G, Stefanos M, Munneke B, West JS, Neuenburg JK, James DF, Hall N, Johnson AJ, Byrd JC.
Jaglowski SM, et al. Among authors: munneke b.
Blood. 2015 Aug 13;126(7):842-50. doi: 10.1182/blood-2014-12-617522. Epub 2015 Jun 26.
Blood. 2015.
PMID: 26116658
Free PMC article.
Clinical Trial.
Item in Clipboard
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Fong L, Hotson A, Powderly JD, Sznol M, Heist RS, Choueiri TK, George S, Hughes BGM, Hellmann MD, Shepard DR, Rini BI, Kummar S, Weise AM, Riese MJ, Markman B, Emens LA, Mahadevan D, Luke JJ, Laport G, Brody JD, Hernandez-Aya L, Bonomi P, Goldman JW, Berim L, Renouf DJ, Goodwin RA, Munneke B, Ho PY, Hsieh J, McCaffery I, Kwei L, Willingham SB, Miller RA.
Fong L, et al. Among authors: munneke b.
Cancer Discov. 2020 Jan;10(1):40-53. doi: 10.1158/2159-8290.CD-19-0980. Epub 2019 Nov 15.
Cancer Discov. 2020.
PMID: 31732494
Free PMC article.
Clinical Trial.
Item in Clipboard
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer.
Baker JB, Dutta D, Watson D, Maddala T, Munneke BM, Shak S, Rowinsky EK, Xu LA, Harbison CT, Clark EA, Mauro DJ, Khambata-Ford S.
Baker JB, et al. Among authors: munneke bm.
Br J Cancer. 2011 Feb 1;104(3):488-95. doi: 10.1038/sj.bjc.6606054. Epub 2011 Jan 4.
Br J Cancer. 2011.
PMID: 21206494
Free PMC article.
Item in Clipboard
Adding confidence to gene expression clustering.
Munneke B, Schlauch KA, Simonsen KL, Beavis WD, Doerge RW.
Munneke B, et al.
Genetics. 2005 Aug;170(4):2003-11. doi: 10.1534/genetics.104.031500. Epub 2005 Jun 8.
Genetics. 2005.
PMID: 15944369
Free PMC article.
Item in Clipboard
The Dutch-Belgian beamline at the ESRF.
Borsboom M, Bras W, Cerjak I, Detollenaere D, Glastra Van Loon D, Goedtkindt P, Konijnenburg M, Lassing P, Levine YK, Munneke B, Oversluizen M, Van Tol R, Vlieg E.
Borsboom M, et al. Among authors: munneke b.
J Synchrotron Radiat. 1998 May 1;5(Pt 3):518-20. doi: 10.1107/S0909049597013484. Epub 1998 May 1.
J Synchrotron Radiat. 1998.
PMID: 15263564
Item in Clipboard
Cite
Cite